By James C. Wang (auth.), Toshiwo Andoh (eds.)
In the mid 80's variety I and II enzymes have been came upon to be the intracellular ambitions of a couple of efficacious anticancer medicines reminiscent of doxorubicin, mitoxantrone, etoposide and camptothecin because of a persisted efforts of many investigators, specifically Leroy Liu and his collaborators at Johns Hopkins collage. Readers will discover a sequence of chapters written by way of researchers actively engaged within the increasing box of topoisomerase and their inhibitors. The sequence of chapters hide overview articles on pharmacology and the molecular mechanism of topoisomerase I- and II-targeting anticancer medicinal drugs in mammals and within the yeast Saccharomyces cerevisiae, which has proved to be an exceptional version organism for stories of anticancer medicines. This quantity compiles up to date info at the topoisomerase-targeting compounds in medical and preclinical improvement as an invaluable and demanding reference publication for college kids and researchers within the box of pharmacology, toxicology, oncology and molecular biology.
Read or Download DNA Topoisomerases in Cancer Therapy: Present and Future PDF
Similar cancer books
Within the mid 80's style I and II enzymes have been chanced on to be the intracellular ambitions of a couple of efficacious anticancer medicines reminiscent of doxorubicin, mitoxantrone, etoposide and camptothecin due to a persevered efforts of many investigators, particularly Leroy Liu and his collaborators at Johns Hopkins collage.
A lot growth has been made in studying and constructing brokers that experience promise, or have already been effectively used, to regard precancerous stipulations or inhibit carcinogenesis. In melanoma Chemoprevention, quantity 1: Promising melanoma Chemopreventive brokers, prime researchers within the discovery and improvement of chemopreventives comprehensively survey all elements of those rising therapeutics.
Taken jointly the information offered during this evaluation, and paintings by way of many different investigators, help the inspiration that DNA excision fix is necessary in a tumor cell's resistance to platinum compounds. Inhibition of this fix process via blend chemotherapy with the excision fix inhibitors HU and Ara-C produces synergistic phone kills and elevated degrees and persistance of DNA interstrand crosslinks.
This quantity makes a speciality of defining the original attributes of utilizing the zebrafish melanoma version for locating very important pathways and capability drug objectives for the therapy of human cancers. utilizing the zebrafish version, the amount explores oncogene and tumor suppressor discovery, chemical genetic techniques, genomics, epigenetics, melanoma imaging, and cellphone transplantation.
- Colon Cancer - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
- Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins
- Nanomedicine for Cancer Therapy: From Chemotherapeutic to Hyperthermia-Based Therapy
- Talking About Treatment: Recommendations for Breast Cancer Adjuvant Treatment (Oxford Studies in Sociolinguistics)
- The Official Patient's Sourcebook on Breast Cancer: A Revised and Updated Directory for the Internet Age
- [sic]: A Memoir
Extra resources for DNA Topoisomerases in Cancer Therapy: Present and Future
Increased error-prone non homologous DNA end-joining-a proposed mechanism of chromosomal instability in Bloom's syndrome, Oncogene. , 2002. Thacker, J. and Ganesh, A. N. DNA-break repair, radioresistance of DNA synthesis, and camptothecin sensitivity in the radiation-sensitive irs mutants: comparisons to ataxia-telangiectasia cells, Mutat Res. 235: 49-58, 1990. Caldecott, K. and Jeggo, P. Cross-sensitivity of gamma-ray-sensitive hamster mutants to cross-linking agents, Mutat Res. 255: 111-21, 1991.
Natl. Acad. Sci. A. 85: 10601064,1988. Stewart, A. , Herrera, R. , and Nordheim, A. Rapid induction of c-fos transcription reveals quantitive linkage of RNA polymerase II and DNA topoisomerase I enzyme activities, Cell. 60: 141-146, 1990. Ljungman, M. and Hanawalt, P. C. The anti-cancer drug camptothecin inhibits elongation but stimulates initiation of RNA polymerase II transcription, Carcinogenesis. 17: 31-35,1996. Muscarella, D. , Rachlinski, M. , and Bloom, S. E. Contribution of gene-specific lesions, DNA-replication-associated damage, and subsequent transcriptional inhibition in topoisomerase inhibitor-mediated apoptosis in lymphoma cells, Exp Cell Res.
G. J. Crystal structure of human topoisomerase I in covalent and noncovalent complexes with DNA, Science. 279: 1504-1513, 1998. Kerrigan, J. E. and Pilch, D. S. A structural model for the ternary cleavable complex formed between human topoisomerase I, DNA, and camptothecin, Biochemistry. 40: 9792-9798,2001. , Collins, J. , Luke, B. , Sayer, J. , Jerina, D. , and Pommier, Y. based active site model, Biochemistry. ,2002. , Laco, G. , Sayer, J. , and Jerina, D. M. Position-specific trapping oftopoisomerase I-DNA cleavage complexes by the intercalated benzo[a]pyrene diol epoxide adducts at the 6-amino group of adenine, Proc Natl Acad Sci USA.